BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5857 related articles for article (PubMed ID: 307959)

  • 1. Relationship between T and B lymphocyte values and prognosis in malignant melanoma.
    Bernengo MG; Capella G; Peruccio M; Zina G
    Br J Dermatol; 1978 Jun; 98(6):655-62. PubMed ID: 307959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of T-lymphocyte levels in malignant melanoma. A five-year follow-up.
    Bernengo MG; Lisa F; Meregalli M; De Matteis A; Zina G
    Cancer; 1983 Nov; 52(10):1841-8. PubMed ID: 6605188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in T and B lymphocyte subpopulations before, during and after chemotherapy for malignant melanoma.
    Bernengo MG; Lisa F; Meregalli M; Doveil GC
    Int J Tissue React; 1984; 6(6):505-11. PubMed ID: 6335712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymostimulin therapy in melanoma patients: correlation of immunologic effects with clinical course.
    Bernengo MG; Fra P; Lisa F; Meregalli M; Zina G
    Clin Immunol Immunopathol; 1983 Sep; 28(3):311-24. PubMed ID: 6603936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Variations of B- and T-lymphocytes in the peripheral blood and variations of the stimulability of cyclic nucleotides in the T-lymphocytes of patients suffering from malignant melanoma (author's transl)].
    Busse E; Rose H; Lehnert W
    Dermatol Monatsschr; 1979 Sep; 165(9):634-41. PubMed ID: 230989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
    Serov AA; Kadagidze ZG
    Vopr Onkol; 1983; 29(12):18-20. PubMed ID: 6607569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly study of melanoma patients II. Changes in serum immunoglobulins and lymphoid cell subpopulations.
    Thatcher N; Swindell R; Crowther D
    Clin Exp Immunol; 1979 Jun; 36(3):456-64. PubMed ID: 487647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell subsets in melanoma patients evaluated by anti-T-cell monoclonal antibodies.
    Bernengo MG; Lisa F; Puiatti P; Meregalli M; Berruto G; Zina G
    Thymus; 1983 Apr; 5(3-4):223-33. PubMed ID: 6224319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responsiveness in patients with choroidal malignant melanoma.
    Priluck IA; Robertson DM; Pritchard DJ; Ilstrup DM
    Am J Ophthalmol; 1979 Feb; 87(2):215-20. PubMed ID: 312019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peripheral blood lymphocytes in melanoma].
    Luchenko IM
    Vopr Onkol; 1977; 23(2):53-6. PubMed ID: 300944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical staging and immunological findings in chronic lymphocytic leukemia.
    Foa R; Catovsky D; Brozovic M; Marsh G; Ooyirilangkumaran T; Cherchi M; Galton DA
    Cancer; 1979 Aug; 44(2):483-7. PubMed ID: 314324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic function in humans before and after hyperthermia and chemotherapy for disseminated malignancy.
    DeHoratius RJ; Hosea JM; Van Epps DE; Reed WP; Edwards WS; Williams RC
    J Natl Cancer Inst; 1977 Apr; 58(4):905-11. PubMed ID: 300437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral lymphocyte count and suppopulations of T and B lymphocytes in benign and malignant diseases.
    Lee YT
    Surg Gynecol Obstet; 1977 Mar; 144(3):435-50. PubMed ID: 300179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T and B lymphocytes in patients with hay fever.
    Małolepszy J; Kraus-Filarska M; Panaszek B; Liebhart E; Szeliga W; Litwa M
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):589-92. PubMed ID: 6970026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunologic abnormalities in amyotrophic lateral sclerosis].
    Khondkarian OA; Gannushkina IV; Zavalishin IA; Zhirnova IG; Nevskaia OM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):195-8. PubMed ID: 3157286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [T-lymphocytes in the peripheral blood. Study on 113 patients with malignant melanoma].
    Klein R; Krüger GR; Sesterhenn K
    Z Hautkr; 1978 Feb; 53(3):62-6. PubMed ID: 305173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related variation in lymphocyte subpopulations.
    Davey FR; Huntington S
    Gerontology; 1977; 23(5):381-9. PubMed ID: 300698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T and B lymphocytes in malignant melanoma patients.
    Babusiková O; Novotná L; Schneková K; Turková D; Havránková M
    Neoplasma; 1976; 23(6):635-44. PubMed ID: 1087378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The reaction of the T-immunity system in patients with malignant skin melanoma and stomach cancer to active nonspecific immunotherapy].
    Glinkina LS; Bruvere RZh
    Vopr Onkol; 1992; 38(6):659-66. PubMed ID: 1300766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lymphocyte populations and serum immunoglobulins in patients with chronic lymphoid leukemia].
    Boretskiĭ VA
    Vrach Delo; 1982 Dec; (12):64-7. PubMed ID: 6984564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 293.